Literature DB >> 16291664

Mutations that activate the silent bgl operon of Escherichia coli confer a growth advantage in stationary phase.

Ranjna Madan1, Roberto Kolter, S Mahadevan.   

Abstract

Wild-type strains of Escherichia coli are unable to utilize aromatic beta-glucosides such as arbutin and salicin because the major genetic system that encodes the functions for their catabolism, the bgl operon, is silent and uninducible. We show that strains that carry an activated bgl operon exhibit a growth advantage over the wild type in stationary phase in the presence of the rpoS819 allele that causes attenuated rpoS regulon expression. Our results indicate a possible evolutionary advantage in retaining the silent bgl operon by wild-type bacteria.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16291664      PMCID: PMC1291259          DOI: 10.1128/JB.187.23.7912-7917.2005

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  32 in total

1.  Mutations enhancing amino acid catabolism confer a growth advantage in stationary phase.

Authors:  E R Zinser; R Kolter
Journal:  J Bacteriol       Date:  1999-09       Impact factor: 3.490

2.  Positive and negative regulation of the bgl operon in Escherichia coli.

Authors:  S Mahadevan; A E Reynolds; A Wright
Journal:  J Bacteriol       Date:  1987-06       Impact factor: 3.490

3.  A bacterial gene involved in transcription antitermination: regulation at a rho-independent terminator in the bgl operon of E. coli.

Authors:  S Mahadevan; A Wright
Journal:  Cell       Date:  1987-07-31       Impact factor: 41.582

4.  A physiological role for DNA supercoiling in the osmotic regulation of gene expression in S. typhimurium and E. coli.

Authors:  C F Higgins; C J Dorman; D A Stirling; L Waddell; I R Booth; G May; E Bremer
Journal:  Cell       Date:  1988-02-26       Impact factor: 41.582

5.  Insertion of DNA activates the cryptic bgl operon in E. coli K12.

Authors:  A E Reynolds; J Felton; A Wright
Journal:  Nature       Date:  1981-10-22       Impact factor: 49.962

6.  Escherichia coli DNA topoisomerase I mutants have compensatory mutations in DNA gyrase genes.

Authors:  S DiNardo; K A Voelkel; R Sternglanz; A E Reynolds; A Wright
Journal:  Cell       Date:  1982-11       Impact factor: 41.582

7.  Beta-glucoside (bgl) operon of Escherichia coli K-12: nucleotide sequence, genetic organization, and possible evolutionary relationship to regulatory components of two Bacillus subtilis genes.

Authors:  K Schnetz; C Toloczyki; B Rak
Journal:  J Bacteriol       Date:  1987-06       Impact factor: 3.490

8.  Enhancement of bacterial gene expression by insertion elements or by mutation in a CAP-cAMP binding site.

Authors:  A E Reynolds; S Mahadevan; S F LeGrice; A Wright
Journal:  J Mol Biol       Date:  1986-09-05       Impact factor: 5.469

9.  Mechanism of catabolite repression in the bgl operon of Escherichia coli: involvement of the anti-terminator BglG, CRP-cAMP and EIIAGlc in mediating glucose effect downstream of transcription initiation.

Authors:  A Gulati; S Mahadevan
Journal:  Genes Cells       Date:  2000-04       Impact factor: 1.891

10.  Regulation of the beta-glucoside system in Escherchia coli K-12.

Authors:  I Prasad; S Schaefler
Journal:  J Bacteriol       Date:  1974-11       Impact factor: 3.490

View more
  17 in total

1.  You cannot tell a book by looking at the cover: Cryptic complexity in bacterial evolution.

Authors:  Qiucen Zhang; Julia Bos; Grigory Tarnopolskiy; James C Sturm; Hyunsung Kim; Nader Pourmand; Robert H Austin
Journal:  Biomicrofluidics       Date:  2014-09-09       Impact factor: 2.800

2.  Catabolism of aromatic β-glucosides by bacteria can lead to antibiotics resistance.

Authors:  Kartika Vashishtha; S Mahadevan
Journal:  Arch Microbiol       Date:  2020-03-04       Impact factor: 2.552

3.  Involvement of the global regulator H-NS in the survival of Escherichia coli in stationary phase.

Authors:  Savita Chib; Subramony Mahadevan
Journal:  J Bacteriol       Date:  2012-07-27       Impact factor: 3.490

4.  Mutations at several loci cause increased expression of ribonucleotide reductase in Escherichia coli.

Authors:  Morgan Anne Feeney; Na Ke; Jon Beckwith
Journal:  J Bacteriol       Date:  2012-01-13       Impact factor: 3.490

5.  Growth Phase-Dependent Chromosome Condensation and Heat-Stable Nucleoid-Structuring Protein Redistribution in Escherichia coli under Osmotic Stress.

Authors:  Nafiseh Rafiei; Martha Cordova; William Wiley Navarre; Joshua N Milstein
Journal:  J Bacteriol       Date:  2019-11-05       Impact factor: 3.490

6.  The β-glucoside (bgl) operon of Escherichia coli is involved in the regulation of oppA, encoding an oligopeptide transporter.

Authors:  Dharmesh Harwani; Parisa Zangoui; S Mahadevan
Journal:  J Bacteriol       Date:  2011-10-21       Impact factor: 3.490

7.  BglJ-RcsB heterodimers relieve repression of the Escherichia coli bgl operon by H-NS.

Authors:  G Raja Venkatesh; Frant Carlot Kembou Koungni; Andreas Paukner; Thomas Stratmann; Birgit Blissenbach; Karin Schnetz
Journal:  J Bacteriol       Date:  2010-10-15       Impact factor: 3.490

8.  Hydrolysis of aromatic β-glucosides by non-pathogenic bacteria confers a chemical weapon against predators.

Authors:  Robert Sonowal; Krithi Nandimath; Sucheta S Kulkarni; Sandhya P Koushika; Vidyanand Nanjundiah; S Mahadevan
Journal:  Proc Biol Sci       Date:  2013-05-15       Impact factor: 5.349

9.  Bacterial stationary-state mutagenesis and Mammalian tumorigenesis as stress-induced cellular adaptations and the role of epigenetics.

Authors:  Tv Karpinets; Dj Greenwood; Ip Pogribny; Nf Samatova
Journal:  Curr Genomics       Date:  2006       Impact factor: 2.236

10.  Effect of Exposure to Chlorhexidine Residues at "During Use" Concentrations on Antimicrobial Susceptibility Profile, Efflux, Conjugative Plasmid Transfer, and Metabolism of Escherichia coli.

Authors:  R Wesgate; S Fanning; Y Hu; J-Y Maillard
Journal:  Antimicrob Agents Chemother       Date:  2020-11-17       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.